Novartis AG (NOVN.SW)
CHF 88.04
(-0.77%)
CHF 88.04
(-0.77%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 7.11 USD | 124.14% |
| 2022 | 3.19 USD | -70.21% |
| 2021 | 10.71 USD | 201.69% |
| 2020 | 3.55 USD | 13.78% |
| 2019 | 3.12 USD | -42.65% |
| 2018 | 5.44 USD | 65.85% |
| 2017 | 3.28 USD | 16.31% |
| 2016 | 2.82 USD | -61.89% |
| 2015 | 7.40 USD | 75.77% |
| 2014 | 4.21 USD | 11.97% |
| 2013 | 3.76 USD | -4.33% |
| 2012 | 3.93 USD | 4.8% |
| 2011 | 3.75 USD | -12.38% |
| 2010 | 4.28 USD | 15.68% |
| 2009 | 3.70 USD | 2.21% |
| 2008 | 3.62 USD | -29.71% |
| 2007 | 5.15 USD | 68.3% |
| 2006 | 3.06 USD | 16.35% |
| 2005 | 2.63 USD | 15.35% |
| 2004 | 2.28 USD | 14.57% |
| 2003 | 1.99 USD | 5.85% |
| 2002 | 1.88 USD | 26.17% |
| 2001 | 1.49 USD | -12.35% |
| 2000 | 1.70 USD | 174.19% |
| 1999 | 0.62 USD | 87.88% |
| 1998 | 0.33 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 1.60 USD | 22.14% |
| 2024 Q1 | 1.31 USD | -68.36% |
| 2024 Q3 | 1.37 USD | -1.25% |
| 2023 FY | - USD | 124.14% |
| 2023 Q2 | 1.11 USD | 1.83% |
| 2023 Q1 | 1.09 USD | 57.97% |
| 2023 Q3 | 0.85 USD | -23.42% |
| 2023 Q4 | 4.14 USD | 387.06% |
| 2022 Q2 | 0.77 USD | -23.0% |
| 2022 Q3 | 0.73 USD | -5.19% |
| 2022 Q4 | 0.69 USD | -5.48% |
| 2022 FY | - USD | -70.21% |
| 2022 Q1 | 1.00 USD | -86.28% |
| 2021 Q2 | 1.29 USD | 41.76% |
| 2021 Q3 | 1.23 USD | -4.65% |
| 2021 Q4 | 7.29 USD | 492.68% |
| 2021 FY | - USD | 201.69% |
| 2021 Q1 | 0.91 USD | -1.09% |
| 2020 FY | - USD | 13.78% |
| 2020 Q2 | 0.82 USD | -14.58% |
| 2020 Q1 | 0.96 USD | 92.0% |
| 2020 Q3 | 0.85 USD | 3.66% |
| 2020 Q4 | 0.92 USD | 8.24% |
| 2019 Q2 | 2.94 USD | 281.82% |
| 2019 Q3 | 0.90 USD | -69.39% |
| 2019 FY | - USD | -42.65% |
| 2019 Q4 | 0.50 USD | -44.44% |
| 2019 Q1 | 0.77 USD | 48.08% |
| 2018 Q1 | 0.87 USD | 2.35% |
| 2018 Q3 | 0.70 USD | -79.04% |
| 2018 FY | - USD | 65.85% |
| 2018 Q4 | 0.52 USD | -25.71% |
| 2018 Q2 | 3.34 USD | 283.91% |
| 2017 Q2 | 0.84 USD | 20.0% |
| 2017 FY | - USD | 16.31% |
| 2017 Q4 | 0.85 USD | -4.49% |
| 2017 Q3 | 0.89 USD | 5.95% |
| 2017 Q1 | 0.70 USD | 75.0% |
| 2016 Q4 | 0.40 USD | -50.62% |
| 2016 FY | - USD | -61.89% |
| 2016 Q1 | 0.85 USD | 93.18% |
| 2016 Q2 | 0.76 USD | -10.59% |
| 2016 Q3 | 0.81 USD | 6.58% |
| 2015 Q4 | 0.44 USD | -44.3% |
| 2015 Q2 | 0.76 USD | -85.93% |
| 2015 Q1 | 5.40 USD | 770.97% |
| 2015 FY | - USD | 75.77% |
| 2015 Q3 | 0.79 USD | 3.95% |
| 2014 Q2 | 1.05 USD | -13.22% |
| 2014 Q1 | 1.21 USD | 45.78% |
| 2014 FY | - USD | 11.97% |
| 2014 Q4 | 0.62 USD | -53.38% |
| 2014 Q3 | 1.33 USD | 26.67% |
| 2013 Q3 | 0.91 USD | -11.65% |
| 2013 FY | - USD | -4.33% |
| 2013 Q2 | 1.03 USD | 5.1% |
| 2013 Q1 | 0.98 USD | 16.67% |
| 2013 Q4 | 0.83 USD | -8.79% |
| 2012 FY | - USD | 4.8% |
| 2012 Q1 | 0.93 USD | 126.83% |
| 2012 Q4 | 0.84 USD | -15.15% |
| 2012 Q3 | 0.99 USD | -9.17% |
| 2012 Q2 | 1.09 USD | 17.2% |
| 2011 Q3 | 1.02 USD | -9.73% |
| 2011 FY | - USD | -12.38% |
| 2011 Q2 | 1.13 USD | -6.61% |
| 2011 Q1 | 1.21 USD | 28.72% |
| 2011 Q4 | 0.41 USD | -59.8% |
| 2010 Q1 | 1.29 USD | 27.72% |
| 2010 FY | - USD | 15.68% |
| 2010 Q4 | 0.94 USD | -5.05% |
| 2010 Q3 | 0.99 USD | -6.6% |
| 2010 Q2 | 1.06 USD | -17.83% |
| 2009 Q1 | 0.87 USD | 27.94% |
| 2009 FY | - USD | 2.21% |
| 2009 Q4 | 1.01 USD | 8.6% |
| 2009 Q3 | 0.93 USD | 3.33% |
| 2009 Q2 | 0.90 USD | 3.45% |
| 2008 Q4 | 0.68 USD | -26.09% |
| 2008 FY | - USD | -29.71% |
| 2008 Q3 | 0.92 USD | -7.07% |
| 2008 Q2 | 0.99 USD | -2.94% |
| 2008 Q1 | 1.02 USD | -57.68% |
| 2007 FY | - USD | 68.3% |
| 2007 Q1 | 0.93 USD | 32.86% |
| 2007 Q2 | 0.86 USD | -7.53% |
| 2007 Q3 | 2.97 USD | 245.35% |
| 2007 Q4 | 2.41 USD | -18.86% |
| 2006 Q4 | 0.70 USD | -15.66% |
| 2006 Q2 | 0.73 USD | -12.05% |
| 2006 Q1 | 0.83 USD | 43.1% |
| 2006 Q3 | 0.83 USD | 13.7% |
| 2006 FY | - USD | 16.35% |
| 2005 Q1 | 0.63 USD | 28.57% |
| 2005 Q3 | 0.71 USD | 31.48% |
| 2005 Q2 | 0.54 USD | -14.29% |
| 2005 Q4 | 0.58 USD | -18.31% |
| 2005 FY | - USD | 15.35% |
| 2004 Q4 | 0.49 USD | -22.22% |
| 2004 Q2 | 0.63 USD | 21.15% |
| 2004 Q3 | 0.63 USD | 0.0% |
| 2004 Q1 | 0.52 USD | 1.96% |
| 2004 FY | - USD | 14.57% |
| 2003 Q4 | 0.51 USD | -1.92% |
| 2003 FY | - USD | 5.85% |
| 2003 Q2 | 0.53 USD | 23.26% |
| 2003 Q1 | 0.43 USD | -8.51% |
| 2003 Q3 | 0.52 USD | -1.89% |
| 2002 Q4 | 0.47 USD | 20.51% |
| 2002 Q3 | 0.39 USD | -29.09% |
| 2002 Q2 | 0.55 USD | 27.91% |
| 2002 Q1 | 0.43 USD | 72.0% |
| 2002 FY | - USD | 26.17% |
| 2001 Q2 | 0.40 USD | -2.44% |
| 2001 Q1 | 0.41 USD | -2.38% |
| 2001 Q4 | 0.25 USD | -43.18% |
| 2001 FY | - USD | -12.35% |
| 2001 Q3 | 0.44 USD | 10.0% |
| 2000 Q4 | 0.42 USD | 27.27% |
| 2000 Q2 | 0.40 USD | -18.37% |
| 2000 Q3 | 0.33 USD | -17.5% |
| 2000 Q1 | 0.49 USD | 0.0% |
| 2000 FY | - USD | 174.19% |
| 1999 FY | - USD | 87.88% |
| 1998 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Roche Holding AG | 14.31 CHF | 50.314% |
| Roche Holding AG | 14.31 CHF | 50.314% |